MALAT1 and lung carcinoma: Gong et al13 found that SNPs in HOTTIP, H19, and CCAT2 were associated with lung cancer risk, and SNPs in MALAT1, H19, CCAT2, HOTAIR, and ANRIL were related to lung cancer patients’ response to platinum‐based chemotherapy.